Incyte to Report First Quarter Financial Results
Incyte has scheduled its first quarter financial results conference call for May 4, 2021, at 8:00 a.m. ET. The press release will be made available at 7:00 a.m. ET on the same day. Interested parties can join the call via domestic dial-in at 877-407-3042 or international dial-in at 201-389-0864, using Conference ID 13718346. A replay of the call will be accessible for 30 days post-event. Investors can watch the live webcast with accompanying slides on Incyte's investor page and access the replay for 90 days.
- None.
- None.
Incyte (Nasdaq:INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, May 4, 2021.
The schedule for the press release and conference call/webcast is as follows:
- Q1 2021 Press Release: May 4, 2021 at 7:00 a.m. ET
- Q1 2021 Conference Call: May 4, 2021 at 8:00 a.m. ET
- Domestic Dial-In Number: 877-407-3042
- International Dial-In Number: 201-389-0864
- Conference ID Number: 13718346
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13718346.
The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for 90 days.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210413005011/en/
FAQ
When is Incyte's Q1 2021 financial results conference call?
What time will the Q1 2021 press release be available?
How can I listen to the Incyte Q1 conference call?
Is there a replay of the Incyte Q1 conference call?